Re-examining the efficacy of b-blockers for the treatment of hypertension: a meta-analysis.
Por: Nadia Khan y Finlay A. McAlister. CMAJ, June 6, 2006, -174(12).
En un recientemente metanálisis publicado, investigadores afirmarón que los beta bloqueadores no deben utilizarse para tratar hipertensión, porque la fisiopatología de hipertensión difiere en pacientes mayores y más jovenes. Diseñamos este metaanálisis para aclarar la eficacia de los beta bloqueadores en los diferentes grupos etarios.
Por: Llisterri JL, Morillas P, Pallarés V, Fácila L, Sanchís C y Sánchez T. – Rev Clin Esp. 2011 Feb;211(2):76-84.
Control of arterial blood pressure (BP) in hypertensive patients differs based on the evaluation procedure. This fact can be enhanced in subjects over 65 years of age. We have studied the degree of BP control with determinations in the office or ambulatory blood pressure monitoring (ABPM).
A multicenter, cross-sectional study was conducted in primary care (PC) and hypertension units in the Valencian Community. The first three hypertensive patients = 65 years who attended the consultation on the first day of visits of the week of each investigator were included in the study. Cardiovascular risk factors, target organ damage and associated cardiovascular disease were recorded. Good clinical control values were defined as < 140/90 in the office and < 130/80 by ABPM for 24-hour according to 2007 ESH/ESC guidelines.
Comentarios recientes